🔬Deep Research

TBPH — Theravance Biopharma Inc · catalysts, narrative & risks

October 31, 2026·17 sourcesTBPH forecast →

As of October 31, 2026, Theravance Biopharma Inc (TBPH) is no longer a standalone publicly traded asset, as it has been acquired by Zymeworks Inc (ZYME) [1][3][16].

AI-assisted research from the K3vl4r desk — not personalized investment advice. More research →